본문 바로가기
KERD
논문KCI 등재후보

Diagnosis and treatment of hypertension in dialysis patients: a systematic review

Yoo Tae-Hyun|Kim In Soo|Kim Sungmin|Kim Jwa-Kyung
대한고혈압학회 (The Korean Society of Hypertension)|2023.01|Clinical Hypertension|제29권 |pp. 24-24|DOI 10.1186/s40885-023-00240-x

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

HypertensionMortalityHemodialysisPeritoneal dialysis

초록

In patients with end-stage renal disease (ESRD) undergoing dialysis, hypertension is common but often inadequately controlled. The prevalence of hypertension varies widely among studies because of differences in the definition of hypertension and the methods of used to measure blood pressure (BP), i.e., peri-dialysis or ambulatory BP monitoring (ABPM). Recently, ABPM has become the gold standard for diagnosing hypertension in dialysis patients. Home BP monitoring can also be a good alternative to ABPM, emphasizing BP measurement outside the hemodialysis (HD) unit. One thing for sure is pre- and post-dialysis BP measurements should not be used alone to diagnose and manage hypertension in dialysis patients. The exact target of BP and the relationship between BP and all-cause mortality or cause-specific mortality are unclear in this population. Many observational studies with HD cohorts have almost universally reported a U-shaped or even an L-shaped association between BP and all-cause mortality, but most of these data are based on the BP measured in HD units. Some data with ABPM have shown a linear association between BP and mortality even in HD patients, similar to the general population. Supporting this, the results of meta-analysis have shown a clear benefit of BP reduction in HD patients. Therefore, further research is needed to determine the optimal target BP in the dialysis population, and for now, an individualized approach is appropriate, with particular emphasis on avoiding excessively low BP. Maintaining euvolemia is of paramount importance for BP control in dialysis patients. Patient heterogeneity and the lack of comparative evidence preclude the recommendation of one class of medication over another for all patients. Recently, however, β-blockers could be considered as a first-line therapy in dialysis patients, as they can reduce sympathetic overactivity and left ventricular hypertrophy, which contribute to the high incidence of arrhythmias and sudden cardiac death. Several studies with mineralocorticoid receptor antagonists have also reported promising results in reducing mortality in dialysis patients. However, safety issues such as hyperkalemia or hypotension should be further evaluated before their use.

Abstract

In patients with end-stage renal disease (ESRD) undergoing dialysis, hypertension is common but often inadequately controlled. The prevalence of hypertension varies widely among studies because of differences in the definition of hypertension and the methods of used to measure blood pressure (BP), i.e., peri-dialysis or ambulatory BP monitoring (ABPM). Recently, ABPM has become the gold standard for diagnosing hypertension in dialysis patients. Home BP monitoring can also be a good alternative to ABPM, emphasizing BP measurement outside the hemodialysis (HD) unit. One thing for sure is pre- and post-dialysis BP measurements should not be used alone to diagnose and manage hypertension in dialysis patients. The exact target of BP and the relationship between BP and all-cause mortality or cause-specific mortality are unclear in this population. Many observational studies with HD cohorts have almost universally reported a U-shaped or even an L-shaped association between BP and all-cause mortality, but most of these data are based on the BP measured in HD units. Some data with ABPM have shown a linear association between BP and mortality even in HD patients, similar to the general population. Supporting this, the results of meta-analysis have shown a clear benefit of BP reduction in HD patients. Therefore, further research is needed to determine the optimal target BP in the dialysis population, and for now, an individualized approach is appropriate, with particular emphasis on avoiding excessively low BP. Maintaining euvolemia is of paramount importance for BP control in dialysis patients. Patient heterogeneity and the lack of comparative evidence preclude the recommendation of one class of medication over another for all patients. Recently, however, β-blockers could be considered as a first-line therapy in dialysis patients, as they can reduce sympathetic overactivity and left ventricular hypertrophy, which contribute to the high incidence of arrhythmias and sudden cardiac death. Several studies with mineralocorticoid receptor antagonists have also reported promising results in reducing mortality in dialysis patients. However, safety issues such as hyperkalemia or hypotension should be further evaluated before their use.

참고문헌 (109)

  1. Sarafidis PA, "Hypertension awareness, treatment, and control in chronic kidney disease", Am J Med, 121(4), pp.332~340 (2008)
  2. Cocchi R, "Prevalence of hypertension in patients on peritoneal dialysis : results of an italian multicentre study", Nephrol Dial Transplant, 14(6), pp.1536~1540 (1999)
  3. Menon MK, "Longterm blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function", Nephrol Dial Transplant, 16(11), pp.2207~2213 (2001)
  4. Kim Hyeon Chang, "Korea hypertension fact sheet 2021: analysis of nationwide population-based data with special focus on hypertension in women", Clinical Hypertension, 28, pp.1~1 (2022), 대한고혈압학회[DOI]
  5. Agarwal R, "Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States", Am J Med, 115(4), pp.291~297 (2003)
  6. Rocco MV, "Risk factors for hypertension in chronic hemodialysis patients : baseline data from the HEMO study", Am J Nephrol, 21(4), pp.280~288 (2001)
  7. Agarwal R, "Epidemiology of interdialytic ambulatory hypertension and the role of volume excess", Am J Nephrol, 34(4), pp.381~390 (2011)
  8. Cheung AK, "Effects of intensive BP Control in CKD", J Am Soc Nephrol, 28(9), pp.2812~2823 (2017)
  9. Selby NM, "The acute cardiac effects of dialysis", Semin Dial, 20(3), pp.220~228 (2007)
  10. Vaios V, "Assessment and Management of Hypertension among patients on peritoneal Dialysis", Clin J Am Soc Nephrol, 14(2), pp.297~305 (2019)
  11. Adriaan Slabbert, "The association between office blood pressure and fluid status using bioimpedance spectroscopy in stable continuous ambulatory peritoneal dialysis patients", Clinical Hypertension, 28, pp.8~8 (2022), 대한고혈압학회[DOI]
  12. K, "DOQI clinical practice guidelines on hypertension", And antihypertensive agents in chronic kidney disease, 2004, pp.43(5 Suppl 1), 1~290
  13. "K", DOQI. Clinical practice guidelines for cardiovascular disease in dialysis patients, 2005, pp.45(4 Suppl 3), 1~153
  14. Rahman M, "A comparison of standardized versus"usual"blood pressure measurements in hemodialysis patients", Am J Kidney Dis, 39(6), pp.1226~1230 (2002)
  15. Agarwal R, "Pre-and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure", Clin J Am Soc Nephrol, 1(3), pp.389~398 (2006)
  16. Sarafidis PA, "Hypertension in dialysis patients : a consensus document by the European Renal and Cardiovascular Medicine(EURECA-m)working group of the european Renal Association-European Dialysis and Transplant Association(ERA-EDTA)and the hypertension and the kidney working group of the European Society of Hypertension(ESH)", Nephrol Dial Transplant, 32(4), pp.620~640 (2017)
  17. 손형은, "Association of ambulatory blood pressure monitoring with renal outcome in patients with chronic kidney disease", Kidney Research and Clinical Practice, 39(1), pp.70~80 (2020), 대한신장학회[DOI]
  18. Sarafidis PA, "Hypertension in dialysis patients : a consensus document by the European Renal and Cardiovascular Medicine(EURECA-m)working group of the european Renal Association-European Dialysis and Transplant Association(ERA-EDTA)and the hypertension and the kidney working group of the European Society of Hypertension(ESH)", J Hypertens, 35(4), pp.657~676 (2017)
  19. Agarwal R, "Blood pressure and mortality among hemodialysis patients", Hypertension, 55(3), pp.762~768 (2010)
  20. Alborzi P, "Home blood pressures are of greater prognostic value than hemodialysis unit recordings", Clin J Am Soc Nephrol, 2(6), pp.1228~1234 (2007)
  21. Agarwal R, "Home blood pressure monitoring improves the diagnosis of hypertension in hemodialysis patients", Kidney Int, 69(5), pp.900~906 (2006)
  22. Bansal N, "Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis : the chronic renal insufficiency cohort study", Hypertension, 65(1), pp.93~100 (2015)
  23. Agarwal R, "Diagnosing hypertension by intradialytic blood pressure recordings", Clin J Am Soc Nephrol, 3(5), pp.1364~1372 (2008)
  24. Rohrscheib MR, "Age-related blood pressure patterns and blood pressure variability among hemodialysis patients", Clin J Am Soc Nephrol, 3(5), pp.1407~1414 (2008)
  25. Lee Jeonghwan, "A new opportunity for Kidney Research and Clinical Practice to make a great leap forward as a Science Citation Index Expanded journal", Kidney Research and Clinical Practice, 40(1), pp.1~5 (2021), 대한신장학회[DOI]
  26. Camafort Miguel, "Intensive blood pressure lowering: a practical review", Clinical Hypertension, 26(4), pp.28~35 (2020), 대한고혈압학회[DOI]
  27. Zager PG, "U” curve association of blood pressure and mortality in hemodialysis patients. Medical directors of Dialysis Clinic, Inc", Kidney Int, 54(2), pp.561~569 (1998)
  28. Hannedouche T, "Multiphasic effects of blood pressure on survival in hemodialysis patients", Kidney Int, 90(3), pp.674~684 (2016)
  29. Miskulin DC, "BP in Dialysis : results of a pilot study", J Am Soc Nephrol, 29(1), pp.307~316 (2018)
  30. Flythe JE, "Association of mortality risk with various definitions of intradialytic hypotension", J Am Soc Nephrol, 26(3), pp.724~734 (2015)
  31. Daugirdas JT, "Measuring intradialytic hypotension to improve quality of care", J Am Soc Nephrol, 26(3), pp.512~514 (2015)
  32. Sands JJ, "Intradialytic hypotension : frequency, sources of variation and correlation with clinical outcome", Hemodial Int, 18(2), pp.415~422 (2014)
  33. Stefánsson BV, "Intradialytic hypotension and risk of cardiovascular disease", Clin J Am Soc Nephrol, 9(12), pp.2124~2132 (2014)
  34. Chang TI, "Intradialytic hypotension and vascular access thrombosis", J Am Soc Nephrol, 22(8), pp.1526~1533 (2011)
  35. Mazzuchi N, "Importance of blood pressure control in hemodialysis patient survival", Kidney Int, 58(5), pp.2147~2154 (2000)
  36. Kalantar-Zadeh K, "Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population : the 58th annual fall conference and scientific sessions", Hypertension, 45(4), pp.811~817 (2005)
  37. Robinson BM, "Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and practice patterns study", Kidney Int, 82(5), pp.570~580 (2012)
  38. Tentori F, "Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization?", J Am Soc Nephrol, 18(8), pp.2377~2384 (2007)
  39. Li Z, "The epidemiology of systolic blood pressure and death risk in hemodialysis patients", Am J Kidney Dis, 48(4), pp.606~615 (2006)
  40. Suzuki H, "Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis : an open-label randomized controlled trial", Am J Kidney Dis, 52(3), pp.501~506 (2008)
  41. Takeda A, "Discordance of influence of hypertension on mortality and cardiovascular risk in hemodialysis patients", Am J Kidney Dis, 45(1), pp.112~118 (2005)
  42. Heerspink HJ, "Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis : a systematic review and meta-analysis of randomised controlled trials", Lancet, 373(9668), pp.1009~1015 (2009)
  43. Agarwal R, "Cardiovascular protection with antihypertensive drugs in dialysis patients : systematic review and meta-analysis", Hypertension, 53(5), pp.860~866 (2009)
  44. Cice G, "Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy : a prospective, placebo-controlled trial", J Am Coll Cardiol, 41(9), pp.1438~1444 (2003)
  45. Zannad F, "Prevention of cardiovascular events in end-stage renal disease : results of a randomized trial of fosinopril and implications for future studies", Kidney Int, 70(7), pp.1318~1324 (2006)
  46. Takahashi A, "Candesartan, an angiotensin II type-1receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis–a randomized study", Nephrol Dial Transplant, 21(9), pp.2507~2512 (2006)
  47. Tepel M, "Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients", Nephrol Dial Transplant, 23(11), pp.3605~3612 (2008)
  48. Amar J, "Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients", Kidney Int, 57(6), pp.2485~2491 (2000)
  49. Klassen PS, "Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis", JAMA, 287(12), pp.1548~1555 (2002)
  50. Foley RN, "Blood pressure and long-term mortality in United States hemodialysis patients : USRDS waves 3 and 4 study", Kidney Int, 62(5), pp.1784~1790 (2002)
  51. Stidley CA, "Changing relationship of blood pressure with mortality over time among hemodialysis patients", J Am Soc Nephrol, 17(2), pp.513~520 (2006)
  52. Wright JT Jr, "A randomized trial of intensive versus standard blood-pressure control", N Engl J Med, 373(22), pp.2103~2116 (2015)
  53. Flythe JE, "Blood pressure and volume management in dialysis : conclusions from a kidney disease : improving global outcomes(KDIGO)Controversies Conference", Kidney Int, 97(5), pp.861~876 (2020)
  54. Cheung AK, "Executive summary of the KDIGO 2021 Clinical Practice Guideline for the management of blood pressure in chronic kidney disease", Kidney Int, 99(3), pp.559~569 (2021)
  55. Jindal K, "Hemodialysis clinical practice guidelines for the canadian society of Nephrology", J Am Soc Nephrol, 17(3 Suppl 1), pp.1~27 (2006)
  56. Hirakata H, "Japanese society for Dialysis Therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis", Ther Apher Dial, 16(5), pp.387~435 (2012)
  57. Kooman J, "EBPG guideline on haemodynamic instability", Nephrol Dial Transplant, 22(Suppl 2), pp.ii22~ii44 (2007)
  58. Inrig JK, "Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients : a secondary analysis of the Dialysis Morbidity and Mortality Wave 2study", Am J Kidney Dis, 54(5), pp.881~890 (2009)
  59. Agarwal R, "Intradialytic hypertension is a marker of volume excess", Nephrol Dial Transplant, 25(10), pp.3355~3361 (2010)
  60. Van Buren PN, "Intradialytic hypertension and the association with interdialytic ambulatory blood pressure", Clin J Am Soc Nephrol, 6(7), pp.1684~1691 (2011)
  61. Udayaraj UP, "Blood pressure and mortality risk on peritoneal dialysis", Am J Kidney Dis, 53(1), pp.70~78 (2009)
  62. Van Biesen W, "Fluid status in peritoneal dialysis patients : the european body composition monitoring(EuroBCM)study cohort", PLoS ONE, 6(2), pp.e17148~ (2011)
  63. Ronco C, "Baseline hydration status in incident peritoneal dialysis patients : the initiative of patient outcomes in dialysis(IPOD-PD study)", Nephrol Dial Transplant, 30(5), pp.849~858 (2015)
  64. Tangwonglert Theerasak, "Changes in extracellular water and left ventricular mass in peritoneal dialysis patients", Kidney Research and Clinical Practice, 40(1), pp.135~142 (2021), 대한신장학회[DOI]
  65. Wang AY, "ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part I-Assessment and Management of various Cardiovascular Risk factors", Perit Dial Int, 35(4), pp.379~387 (2015)
  66. Alexandrou ME, "Ambulatory blood pressure profile and blood pressure variability in peritoneal dialysis compared with hemodialysis and chronic kidney disease patients", Hypertens Res, 43(9), pp.903~913 (2020)
  67. Liu JH, "Association between pulse pressure and 30-month all-cause mortality in peritoneal dialysis patients", Am J Hypertens, 21(12), pp.1318~1323 (2008)
  68. Fang W, "Association between pulse pressure and mortality in patients undergoing peritoneal dialysis", Perit Dial Int, 29(2), pp.163~170 (2009)
  69. Afshinnia F, "Reverse epidemiology of blood pressure in Peritoneal Dialysis Associated with dynamic deterioration of left ventricular function", Perit Dial Int, 36(2), pp.154~162 (2016)
  70. Goldfarb-Rumyantzev AS, "The association between BP and mortality in patients on chronic peritoneal dialysis", Nephrol Dial Transplant, 20(8), pp.1693~1701 (2005)
  71. 신진호, "The roles of sodium and volume overload on hypertension in chronic kidney disease", Kidney Research and Clinical Practice, 40(4), pp.542~554 (2021), 대한신장학회[DOI]
  72. Sinha AD, "Can chronic volume overload be recognized and prevented in hemodialysis patients? The pitfalls of the clinical examination in assessing volume status", Semin Dial, 22(5), pp.480~482 (2009)
  73. Nongnuch A, "Increased postdialysis systolic blood pressure is associated with extracellular overhydration in hemodialysis outpatients", Kidney Int, 87(2), pp.452~457 (2015)
  74. Günal AI, "Strict volume control normalizes hypertension in peritoneal dialysis patients", Am J Kidney Dis, 37(3), pp.588~593 (2001)
  75. Abu-Alfa AK, "Approach to fluid management in peritoneal dialysis : a practical algorithm", Kidney Int Suppl, (81), pp.S8~S16 (2002)
  76. Agarwal R, "Dry-weight reduction in hypertensive hemodialysis patients(DRIP) : a randomized, controlled trial", Hypertension, 53(3), pp.500~507 (2009)
  77. Alissa A. Frame, "Renal sodium handling and sodium sensitivity", Kidney Research and Clinical Practice, 36(2), pp.117~131 (2017), 대한신장학회
  78. Kooman JP, "Sodium balance in hemodialysis therapy", Semin Dial, 16(5), pp.351~355 (2003)
  79. Tomson CR, "Advising dialysis patients to restrict fluid intake without restricting sodium intake is not based on evidence and is a waste of time", Nephrol Dial Transplant, 16(8), pp.1538~1542 (2001)
  80. Davies S, "The effects of low-sodium peritoneal dialysis fluids on blood pressure, thirst and volume status", Nephrol Dial Transplant, 24(5), pp.1609~1617 (2009)
  81. Kwang-Il Kim, "2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations", Clinical Hypertension, 25(4), pp.75~88 (2019), 대한고혈압학회[DOI]
  82. Mancia G, "2013 ESH", ESC Guidelines for the management of arterial hypertension : the Task Force for the management of arterial hypertension of the European Society of Hypertension(ESH)and of the European Society of Cardiology(ESC), 2013, pp.31(7), 1281~1357
  83. Ruggenenti P, "Ramipril and Cardiovascular Outcomes in patients on maintenance hemodialysis : the ARCADIA Multicenter Randomized Controlled Trial", Clin J Am Soc Nephrol, 16(4), pp.575~587 (2021)
  84. Peters CD, "No significant effect of angiotensin II receptor blockade on intermediate cardiovascular end points in hemodialysis patients", Kidney Int, 86(3), pp.625~637 (2014)
  85. Iseki K, "Effects of angiotensin receptor blockade(ARB)on mortality and cardiovascular outcomes in patients with longterm haemodialysis : a randomized controlled trial", Nephrol Dial Transplant, 28(6), pp.1579~1589 (2013)
  86. Tai DJ, "Cardiovascular effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in hemodialysis : a meta-analysis", Clin J Am Soc Nephrol, 5(4), pp.623~630 (2010)
  87. Zoccali C, "Pleiotropic effects of angiotensin II blockers in hemodialysis patients : myth or reality?", Kidney Int, 86(3), pp.469~471 (2014)
  88. Agarwal R, "Hypertension in hemodialysis patients treated with atenolol or lisinopril : a randomized controlled trial", Nephrol Dial Transplant, 29(3), pp.672~681 (2014)
  89. Zoccali C, "Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease", Circulation, 105(11), pp.1354~1359 (2002)
  90. Denker MG, "Antihypertensive medications in end-stage renal disease", Semin Dial, 28(4), pp.330~336 (2015)
  91. Jadoul M, "Modifiable practices associated with sudden death among hemodialysis patients in the Dialysis Outcomes and practice patterns study", Clin J Am Soc Nephrol, 7(5), pp.765~774 (2012)
  92. Weir MA, "β-Blocker dialyzability and mortality in older patients receiving hemodialysis", J Am Soc Nephrol, 26(4), pp.987~996 (2015)
  93. Wu PH, "β-blocker dialyzability and the risk of mortality and cardiovascular events in patients undergoing hemodialysis", Nephrol Dial Transplant, 35(11), pp.1959~1965 (2020)
  94. Tella A, "β-Blocker Use and Cardiovascular Outcomes in Hemodialysis : a systematic review", Kidney Med, 4(5), pp.100460~ (2022)
  95. London GM, "Salt and water retention and calcium blockade in uremia", Circulation, 82(1), pp.105~113 (1990)
  96. Aslam S, "Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis", Kidney Int, 70(12), pp.2109~2115 (2006)
  97. Pantosti A, "Inferring the potential success of pneumococcal vaccination in Italy : serotypes and antibiotic resistance of Streptococcus pneumoniae isolates from invasive diseases", Microb Drug Resist, 9(Suppl 1), pp.61~68 (2003)
  98. Matsumoto Y, "Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients", J Am Coll Cardiol, 63(6), pp.528~536 (2014)
  99. Lin C, "Long-Term Effects of low-dose spironolactone on chronic Dialysis patients : a randomized placebo-controlled study", J Clin Hypertens(Greenwich), 18(2), pp.121~128 (2016)
  100. Kramann R, "Medical options to fight mortality in end-stage renal disease : a review of the literature", Nephrol Dial Transplant, 27(12), pp.4298~4307 (2012)
  101. Agarwal A, "Mineralocorticoid receptor antagonists in ESKD", Clin J Am Soc Nephrol, 15(7), pp.1047~1049 (2020)
  102. Walsh M, "The safety of Eplerenone in Hemodialysis Patients : a Noninferiority Randomized Controlled Trial", Clin J Am Soc Nephrol, 10(9), pp.1602~1608 (2015)
  103. Choi SI, "Prevalence of resistant hypertension and associated factors for blood pressure control status with optimal medical therapy using korean ambulatory blood pressure monitoring registry data", Clin Hypertens, 22, pp.8~ (2015)
  104. Mallamaci F, "Treatment-resistant hypertension in the hemodialysis population : a 44-h ambulatory blood pressure monitoringbased study", J Hypertens, 38(9), pp.1849~1856 (2020)
  105. Zoccali C, "Chronic fluid overload and mortality in ESRD", J Am Soc Nephrol, 28(8), pp.2491~2497 (2017)
  106. Mechta Nielsen T, "Adherence to medication in patients with chronic kidney disease : a systematic review of qualitative research", Clin Kidney J, 11(4), pp.513~527 (2018)
  107. Ross EA, "Strategy for the treatment of noncompliant hypertensive hemodialysis patients", Int J Artif Organs, 25(11), pp.1061~1065 (2002)
  108. Hörl MP, "Drug therapy for hypertension in hemodialysis patients", Semin Dial, 17(4), pp.288~294 (2004)
  109. Scalise F, "Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis", J Hypertens, 38(5), pp.936~942 (2020)

관련 논문AI추천

Optimal blood pressure target and measurement in patients with chronic kidney disease김수완, 김창성, 마성권, 배은희, 최홍상대한내과학회 · The Korean Journal of Internal Medicine2019 · 제34권 제6호Which dialysis unit blood pressure is the most accurate for predicting home blood pressure in patients undergoing hemodialysis?오동진, 윤인철, 최혜민대한내과학회 · The Korean Journal of Internal Medicine2017 · 제32권 제1호Blood pressure control in patients with chronic kidney diseaseJee Young Lee, Seung Hyeok Han대한내과학회 · The Korean Journal of Internal Medicine2021 · 제36권 제4호Short-term blood pressure variability as a potential therapeutic target for kidney diseaseJhee Jong Hyun, Ko Ye Eun대한고혈압학회 · Clinical Hypertension2023 · 제29권 Accelerated progression of arterial stiffness in dialysis patients compared with the general populationAleksandar Sikole, Kosta Sotiroski, Pavlina Janakievska, Petar Avramovski대한내과학회 · The Korean Journal of Internal Medicine2013 · 제28권 제4호Effects of Lowering Dialysate Calcium Concentrations on Arterial Stiffness in Patients Undergoing Hemodialysis문성진, 박형천, 하성규, Jae Sung Lee, Jwa-Kyung Kim, Soung Rok Sim, Sung Chang Bae대한내과학회 · The Korean Journal of Internal Medicine2011 · 제26권 제3호

이 간행물의 다른 논문 (32건)

Withdrawal of antihypertensaive medication in young to middle-aged adults: a prospective, single-group, intervention study이해영, 이경숙pp. 1-1Role of home blood pressure monitoring in resistant hypertension김혜미, 신진호pp. 2-2Ideal cardiovascular health metrics and the risk of nonalcoholic fatty liver disease in Korean adultsJung Sun Jae, Kim Seung Up, 김현창, 심선영pp. 3-3The association between carbon and nitrogen stable isotope ratios of human hair and hypertensionJong‑Ku Park, 안성복pp. 4-4Fok I and Bsm I gene polymorphism of vitamin D receptor and essential hypertension: a mechanistic linkRajesh Kumar Khare, Priyanka Thapa Manger, Richa Awasthipp. 5-5
원문 보기